SMTL ID : 1agn.4 (3 other biounits)

X-RAY STRUCTURE OF HUMAN SIGMA ALCOHOL DEHYDROGENASE

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.00 Å

Oligo State

homo-tetramer

Ligands

16 x ZN: ZINC ION(Non-covalent)

ZN.1: 5 residues within 4Å: Chain A: C.97, R.98, C.100, C.103, C.111 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.97, A:C.100, A:C.103, A:C.111 ZN.2: 5 residues within 4Å: Chain A: C.46, H.67, C.173 Ligands: ACT.6, NAD.10 3 PLIP interactions: 3 interactions with chain A Metal complexes: A:C.46, A:H.67, A:C.173 ZN.3: 3 residues within 4Å: Chain A: H.270 Ligands: ACT.7, NAD.10 2 PLIP interactions: 1 interactions with chain A, 1 Ligand-Ligand interactions Metal complexes: A:H.270, ACT.7 ZN.4: 4 residues within 4Å: Chain A: F.61, H.137 Chain B: E.356, E.359 3 PLIP interactions: 2 interactions with chain B, 1 interactions with chain A Metal complexes: B:E.356, B:E.359, A:H.137 ZN.5: 3 residues within 4Å: Chain A: D.340 Ligands: ACT.8, ACT.9 2 PLIP interactions: 2 interactions with chain A Metal complexes: A:D.340, A:D.340 ZN.11: 5 residues within 4Å: Chain B: C.97, R.98, C.100, C.103, C.111 4 PLIP interactions: 4 interactions with chain B Metal complexes: B:C.97, B:C.100, B:C.103, B:C.111 ZN.12: 5 residues within 4Å: Chain B: C.46, T.48, H.67, C.173 Ligands: ACT.16 3 PLIP interactions: 3 interactions with chain B Metal complexes: B:C.46, B:H.67, B:C.173 ZN.13: 3 residues within 4Å: Chain B: H.270 Ligands: ACT.17, NAD.18 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:H.270 ZN.14: 2 residues within 4Å: Chain B: E.251, E.255 3 PLIP interactions: 3 interactions with chain B Metal complexes: B:E.251, B:E.255, B:E.255 ZN.15: 1 residues within 4Å: Chain B: H.137 1 PLIP interactions: 1 interactions with chain B Metal complexes: B:H.137 ZN.19: 6 residues within 4Å: Chain C: C.97, R.98, C.100, C.103, C.111, I.112 4 PLIP interactions: 4 interactions with chain C Metal complexes: C:C.97, C:C.100, C:C.103, C:C.111 ZN.20: 6 residues within 4Å: Chain C: C.46, T.48, H.67, C.173 Ligands: ACT.22, NAD.25 3 PLIP interactions: 3 interactions with chain C Metal complexes: C:C.46, C:H.67, C:C.173 ZN.21: 3 residues within 4Å: Chain C: H.270 Ligands: ACT.23, NAD.25 2 PLIP interactions: 1 interactions with chain C, 1 Ligand-Ligand interactions Metal complexes: C:H.270, ACT.23 ZN.26: 5 residues within 4Å: Chain D: C.97, C.100, C.103, C.111, I.112 4 PLIP interactions: 4 interactions with chain D Metal complexes: D:C.97, D:C.100, D:C.103, D:C.111 ZN.27: 5 residues within 4Å: Chain D: C.46, T.48, H.67, C.173 Ligands: NAD.30 3 PLIP interactions: 3 interactions with chain D Metal complexes: D:C.46, D:H.67, D:C.173 ZN.28: 2 residues within 4Å: Chain D: H.270 Ligands: NAD.30 1 PLIP interactions: 1 interactions with chain D Metal complexes: D:H.270

10 x ACT: ACETATE ION(Non-functional Binders)

ACT.6: 8 residues within 4Å: Chain A: C.46, T.48, H.67, F.93, M.140, C.173 Ligands: ZN.2, NAD.10 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:F.93 Hydrogen bonds: A:T.48 Salt bridges: A:H.67 ACT.7: 3 residues within 4Å: Chain A: H.270 Ligands: ZN.3, NAD.10 1 PLIP interactions: 1 interactions with chain A Salt bridges: A:H.270 ACT.8: 2 residues within 4Å: Chain A: D.340 Ligands: ZN.5 No protein-ligand interaction detected (PLIP) ACT.9: 2 residues within 4Å: Chain A: D.340 Ligands: ZN.5 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:D.342 Salt bridges: A:K.337 ACT.16: 7 residues within 4Å: Chain B: T.48, M.57, H.67, M.140, V.293 Ligands: ZN.12, NAD.18 4 PLIP interactions: 4 interactions with chain B Hydrophobic interactions: B:T.48, B:V.293 Hydrogen bonds: B:T.48 Salt bridges: B:H.67 ACT.17: 4 residues within 4Å: Chain B: L.223, H.270 Ligands: ZN.13, NAD.18 1 PLIP interactions: 1 interactions with chain B Salt bridges: B:H.270 ACT.22: 7 residues within 4Å: Chain C: T.48, H.67, F.93, M.140, V.293 Ligands: ZN.20, NAD.25 3 PLIP interactions: 3 interactions with chain C Hydrophobic interactions: C:V.293 Hydrogen bonds: C:T.48 Salt bridges: C:H.67 ACT.23: 4 residues within 4Å: Chain C: L.223, H.270 Ligands: ZN.21, NAD.25 1 PLIP interactions: 1 interactions with chain C Salt bridges: C:H.270 ACT.24: 4 residues within 4Å: Chain C: E.356, E.359 Chain D: P.135, H.137 3 PLIP interactions: 2 interactions with chain D, 1 interactions with chain C Hydrogen bonds: D:T.127 Salt bridges: D:H.137 Hydrophobic interactions: C:E.359 ACT.29: 6 residues within 4Å: Chain D: T.48, F.93, M.140, V.293, V.317 Ligands: NAD.30 2 PLIP interactions: 2 interactions with chain D Hydrophobic interactions: D:V.293 Hydrogen bonds: D:T.48

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)

NAD.10: 33 residues within 4Å: Chain A: C.46, R.47, T.48, H.51, C.173, T.177, G.198, L.199, G.200, G.201, V.202, G.203, D.222, L.223, N.224, K.227, V.267, I.268, G.269, H.270, T.273, V.291, G.292, V.293, C.316, V.317, F.318, L.361, R.368 Ligands: ZN.2, ZN.3, ACT.6, ACT.7 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:T.177, A:V.202 Hydrogen bonds: A:R.47, A:H.51, A:T.177, A:L.199, A:L.199, A:G.200, A:G.201, A:V.202, A:G.203, A:L.223, A:I.268, A:H.270, A:V.293, A:C.316, A:F.318 Salt bridges: A:R.47, A:R.368 NAD.18: 28 residues within 4Å: Chain B: C.46, R.47, T.48, H.51, C.173, T.177, G.198, L.199, G.200, G.201, V.202, D.222, L.223, K.227, I.268, G.269, H.270, V.291, G.292, V.293, C.316, V.317, F.318, L.361, R.368 Ligands: ZN.13, ACT.16, ACT.17 20 PLIP interactions: 20 interactions with chain B Hydrophobic interactions: B:T.177, B:V.202 Hydrogen bonds: B:R.47, B:H.51, B:L.199, B:L.199, B:G.201, B:V.202, B:D.222, B:L.223, B:K.227, B:K.227, B:I.268, B:H.270, B:V.291, B:V.293, B:F.318 Salt bridges: B:R.47, B:K.227, B:R.368 NAD.25: 27 residues within 4Å: Chain C: C.46, R.47, T.48, H.51, C.173, T.177, G.198, L.199, G.200, G.201, V.202, D.222, L.223, K.227, I.268, G.269, H.270, V.291, G.292, V.293, C.316, F.318, R.368 Ligands: ZN.20, ZN.21, ACT.22, ACT.23 17 PLIP interactions: 17 interactions with chain C Hydrophobic interactions: C:T.177, C:V.202 Hydrogen bonds: C:R.47, C:H.51, C:T.177, C:L.199, C:L.199, C:G.201, C:V.202, C:L.223, C:I.268, C:V.293, C:C.316, C:F.318 Salt bridges: C:R.47, C:K.227, C:R.368 NAD.30: 27 residues within 4Å: Chain D: C.46, R.47, T.48, H.51, C.173, T.177, L.199, G.200, G.201, V.202, D.222, L.223, N.224, K.227, I.268, G.269, H.270, V.291, G.292, V.293, C.316, V.317, F.318, R.368 Ligands: ZN.27, ZN.28, ACT.29 15 PLIP interactions: 15 interactions with chain D Hydrophobic interactions: D:T.177 Hydrogen bonds: D:R.47, D:H.51, D:L.199, D:L.199, D:G.201, D:V.202, D:G.203, D:L.223, D:I.268, D:V.293, D:C.316, D:F.318 Salt bridges: D:R.47, D:R.368

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xie, P. et al., X-ray structure of human class IV sigmasigma alcohol dehydrogenase. Structural basis for substrate specificity. J.Biol.Chem. (1997)

Release Date

1997-03-12

Peptides

HUMAN SIGMA ALCOHOL DEHYDROGENASE: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

B
D

C
A

D
C

HUMAN SIGMA ALCOHOL DEHYDROGENASE

Related Entries With Identical Sequence